Valuation (17%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.15 | 25.98 |
| PEG Ratio (TTM) | -0.02 | 3.56 |
| P/S Ratio (TTM) | 1.03 | 5.71 |
| P/B Ratio (TTM) | 1.78 | 11.29 |
| P/FCF Ratio (TTM) | N/A | 30.31 |
| Price to 5YR AVG Earnings Ratio | -0.06 | 19.54 |
| Price to 5YR AVG FCF Ratio | -3.27 | 141.27 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -16.26% | 4.91% |
| ROE (TTM) | -135.56% | 57.54% |
| Net Profit Margin (TTM) | -43.60% | 0.07% |
| ROIC 5YR AVG | -3.91% | 11.96% |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 87.10% | -94.34% | -335.05% |
| Revenue | 38.13% | 30.95% | 4.78% |
| Net Income | 85.02% | -116.76% | -351.50% |
| Cash Flow | -25.00% | 46.49% | 4.02% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.48 | 1.28 |
| Quick Ratio (TTM) | 0.47 | 1.25 |
| D/E Ratio (TTM) | 0.69 | 1.21 |
| Interest Coverage (TTM) | -37.05 | 8.43 |
| Piotroski F-Score | 2 | 7 |
| Altman Z-Score | N/A | 5.52 |
| LTL to 5YR AVG FCF | -1.29 | 12.65 |
| Shares Outstanding Growth 5YR AVG | 2.13% | 11.42% |